Literature DB >> 27065088

Recent advances in viral evasion of the MHC Class I processing pathway.

Anouk Bc Schuren1, Ana I Costa1, Emmanuel Jhj Wiertz2.   

Abstract

T-cell mediated adaptive immunity against viruses relies on recognition of virus-derived peptides by CD4(+) and CD8(+) T cells. Detection of pathogen-derived peptide-MHC-I complexes triggers CD8(+) T cells to eliminate the infected cells. Viruses have evolved several mechanisms to avoid recognition, many of which target the MHC-I antigen-processing pathway. While many immune evasion strategies have been described in the context of herpesvirus infections, it is becoming clear that this 'disguise' ability is more widespread. Here, we address recent findings in viral evasion of the MHC-I antigen presentation pathway and the impact on CD8(+) T cell responses.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27065088     DOI: 10.1016/j.coi.2016.02.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  30 in total

1.  Cutting Edge: The Aging Immune System Reveals the Biological Impact of Direct Antigen Presentation on CD8 T Cell Responses.

Authors:  Jennifer L Uhrlaub; Megan J Smithey; Janko Nikolich-Žugich
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

Review 2.  Herpesvirus microRNAs for use in gene therapy immune-evasion strategies.

Authors:  S T F Bots; R C Hoeben
Journal:  Gene Ther       Date:  2017-05-09       Impact factor: 5.250

Review 3.  Cellular allorecognition and its roles in Dictyostelium development and social evolution.

Authors:  Peter Kundert; Gad Shaulsky
Journal:  Int J Dev Biol       Date:  2019       Impact factor: 2.203

4.  The Obligate Intracellular Bacterium Orientia tsutsugamushi Targets NLRC5 To Modulate the Major Histocompatibility Complex Class I Pathway.

Authors:  Kyle G Rodino; Haley E Adcox; Rebecca K Martin; Vaidehi Patel; Daniel H Conrad; Jason A Carlyon
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

5.  Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.

Authors:  Ioannis Gavvovidis; Matthias Leisegang; Gerald Willimsky; Natalie Miller; Paul Nghiem; Thomas Blankenstein
Journal:  Clin Cancer Res       Date:  2018-04-18       Impact factor: 12.531

6.  Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation.

Authors:  Michael L van de Weijer; Anouk B C Schuren; Dick J H van den Boomen; Arend Mulder; Frans H J Claas; Paul J Lehner; Robert Jan Lebbink; Emmanuel J H J Wiertz
Journal:  J Cell Sci       Date:  2017-07-25       Impact factor: 5.285

7.  Recent advances in CMV tropism, latency, and diagnosis during aging.

Authors:  Sean X Leng; Jeremy Kamil; John G Purdy; Niels A Lemmermann; Matthias J Reddehase; Felicia D Goodrum
Journal:  Geroscience       Date:  2017-07-05       Impact factor: 7.713

Review 8.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Expression of the Pseudorabies Virus gB Glycoprotein Triggers NK Cell Cytotoxicity and Increases Binding of the Activating NK Cell Receptor PILRβ.

Authors:  Steffi De Pelsmaeker; Evelien Dierick; Barbara Klupp; Thomas C Mettenleiter; Claudia Cantoni; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 10.  Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.

Authors:  Katherine S Forsyth; Laurence C Eisenlohr
Journal:  Curr Opin Immunol       Date:  2016-04-24       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.